Genetic Mutation That Opens Door in Combating Age-Related Diseases

by Dr. Trupti Shirole on  December 17, 2016 at 10:22 AM Research News
RSS Email Print This Page Comment bookmark
Font : A-A+

The NADPH Oxidase complex attacks blood vessels, the heart lining, joints and the brain when placed under metabolic stress, causing most of the diseases of ageing. However it has another vital role in helping cells to 'talk' to each other, which means that humans need the complex in order to live.
 Genetic Mutation That Opens Door in Combating Age-Related Diseases
Genetic Mutation That Opens Door in Combating Age-Related Diseases

Researchers at the University of Surrey, in collaboration with the Universities of Reading and Cologne, and the Royal Berkshire Hospital, have discovered that it is possible to stop the activation of this group of proteins (NADPH Oxidase) known to cause most of the diseases of ageing. This will potentially pave the way for the development of drugs to treat a range of age-related diseases.

The new research has found that the natural mutation SNP (single nucleotide polymorphism) protects against cardiovascular disease and also affects the activation of NADPH oxidase.

By identifying the molecular mechanism of an SNP, the research enables the design of drugs that will prevent the activation process in conditions of stress, without affecting the function of NADPH Oxidase in cell health. The researchers believe it will lead to the development of drugs to treat heart disease, diabetes, arthritis and dementia, and also fibrosis in the lungs.

In addition, the research has exciting implications for personalized medicine - a concept which is likely to change the face of healthcare in the future - as it will be possible, in theory, to give patients tailored doses of medicine depending on the SNP mutations they have.

Dr. Brendan Howlin, Director of Postgraduate Research at the University of Surrey, said: "This breakthrough could have a revolutionary impact on healthcare and individuals by tackling two of the key challenges in healthcare today: an ageing population and a growing requirement for personalized medicine. Since the initial research, we have developing a series of drugs that prevent the activation process, and are now working on bringing these drugs to market."

Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions
Advertisement

Recommended Reading

More News on:

Genetics and Stem Cells Genetic Testing of Diseases Crigler-Najjar Syndrome Gilbertís Syndrome McArdle Disease Christianson Syndrome Apert Syndrome 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive